全文获取类型
收费全文 | 1831篇 |
免费 | 211篇 |
出版年
2022年 | 16篇 |
2021年 | 23篇 |
2020年 | 11篇 |
2019年 | 19篇 |
2018年 | 28篇 |
2017年 | 20篇 |
2016年 | 36篇 |
2015年 | 62篇 |
2014年 | 69篇 |
2013年 | 66篇 |
2012年 | 79篇 |
2011年 | 107篇 |
2010年 | 71篇 |
2009年 | 61篇 |
2008年 | 79篇 |
2007年 | 111篇 |
2006年 | 85篇 |
2005年 | 87篇 |
2004年 | 87篇 |
2003年 | 71篇 |
2002年 | 83篇 |
2001年 | 66篇 |
2000年 | 61篇 |
1999年 | 56篇 |
1998年 | 34篇 |
1997年 | 28篇 |
1996年 | 24篇 |
1995年 | 19篇 |
1994年 | 20篇 |
1993年 | 18篇 |
1992年 | 29篇 |
1991年 | 21篇 |
1990年 | 24篇 |
1989年 | 23篇 |
1988年 | 26篇 |
1987年 | 25篇 |
1986年 | 19篇 |
1985年 | 27篇 |
1984年 | 20篇 |
1983年 | 17篇 |
1982年 | 15篇 |
1980年 | 11篇 |
1979年 | 11篇 |
1977年 | 15篇 |
1976年 | 12篇 |
1974年 | 13篇 |
1972年 | 8篇 |
1971年 | 14篇 |
1970年 | 11篇 |
1965年 | 8篇 |
排序方式: 共有2042条查询结果,搜索用时 31 毫秒
941.
Michael Siu Richard Pastor Wendy Liu Kathy Barrett Megan Berry Wade S. Blair Christine Chang Jacob Z. Chen Charles Eigenbrot Nico Ghilardi Paul Gibbons Haiying He Christopher A. Hurley Jane R. Kenny S. Cyrus Khojasteh Hoa Le Leslie Lee Joseph P. Lyssikatos Deepak Sampath 《Bioorganic & medicinal chemistry letters》2013,23(17):5014-5021
The advancement of a series of ligand efficient 2-amino-[1,2,4]triazolo[1,5-a]pyridines, initially identified from high-throughput screening, to a JAK2 inhibitor with pharmacodynamic activity in a mouse xenograft model is disclosed. 相似文献
942.
Christopher A. Hurley Wade S. Blair Richard J. Bull Christine Chang Peter H. Crackett Gauri Deshmukh Hazel J. Dyke Rina Fong Nico Ghilardi Paul Gibbons Peter R. Hewitt Adam Johnson Tony Johnson Jane R. Kenny Pawan Bir Kohli Janusz J. Kulagowski Marya Liimatta Patrick J. Lupardus Mark Zak 《Bioorganic & medicinal chemistry letters》2013,23(12):3592-3598
The identification of a novel fused triazolo-pyrrolopyridine scaffold, optimized derivatives of which display nanomolar inhibition of Janus kinase 1, is described. Prototypical example 3 demonstrated lower cell potency shift, better permeability in cells and higher oral exposure in rat than the corresponding, previously reported, imidazo-pyrrolopyridine analogue 2. Examples 6, 7 and 18 were subsequently identified from an optimization campaign and demonstrated modest selectivity over JAK2, moderate to good oral bioavailability in rat with overall pharmacokinetic profiles comparable to that reported for an approved pan-JAK inhibitor (tofacitinib). 相似文献
943.
Amber Thaxton Sari Izenwasser Dean Wade Edwin D. Stevens David L. Mobley Vivian Jaber Stacey A. Lomenzo Mark L. Trudell 《Bioorganic & medicinal chemistry letters》2013,23(15):4404-4407
A series of 3-aryl-3-arylmethoxy-azetidines were synthesized and evaluated for binding affinities at dopamine and serotonin transporters. The 3-aryl-3-arylmethoxyazetidines were generally SERT selective with the dichloro substituted congener 7c (Ki = 1.0 nM) and the tetrachloro substituted derivative 7i (Ki = 1.3 nM) possessing low nanomolar affinity for the SERT. The 3-(3,4-dichlorophenyl-3-phenylmethoxyazetidine (7g) exhibited moderate affinity at both DAT and SERT transporters and suggests that substitution of the aryl rings can be used to tune the mononamine transporter affinity. 相似文献
944.
945.
946.
We investigate the generation and decay of interspecific disequilibrium (ID) between organelle and symbiont genomes as a function of the rate of horizontal transmission. We show that rare horizontal transmission greatly diminishes the covariance between organelle and symbiont genomes. This result has two important implications. First, a low level of ID does not indicate low levels of vertical transmission. Second, even with low levels of horizontal transmission, the additive effects of host and symbiont loci will determine the response to selection, while epistatic effects will not be selectable. 相似文献
947.
The discovery of a small-molecule allosteric inhibitor of the CDC34 ubiquitin-conjugating enzyme (E2) by Ceccarelli et?al. raises the possibility that it will be generally feasible to selectively inhibit ubiquitin transfer at this central step in the ubiquitin pathway. 相似文献
948.
Chan AK Ilias-Khan NA Xian H Inman C Martin WH 《Journal of applied physiology (Bethesda, Md. : 1985)》2011,111(6):1546-1553
Treadmill exercise capacity in resting metabolic equivalents (METs) and stress hemodynamic, electrocardiographic (ECG), and myocardial perfusion imaging (MPI) responses are independently predictive of adverse clinical events. However, limited data exist for arm ergometer stress testing (AXT) in patients who cannot perform leg exercise because of lower extremity disabilities. We sought to determine the extent to which AXT METs, hemodynamic, ECG, and MPI responses to arm exercise add independent incremental value to demographic and clinical variables for prediction of all-cause mortality, myocardial infarction (MI), or late coronary revascularization, individually or as a composite. A prospective cohort of 186 patients aged 64 ± 10 (SD) yr, unable to perform lower extremity exercise, underwent AXT MPI for clinical reasons between 1997 and 2002, and were followed for 62 ± 23 mo, to an endpoint of death or 12/31/2006. Average annual rates were 5.4% for mortality, 2.2% for MI, 2.5% for late coronary revascularization, and 8.0% for combined events. After adjustment for age and clinical variables, AXT METs [P < 0.05; hazard ratio (HR) = 0.59; confidence interval (CI) = 0.35-0.84] and abnormal MPI (P < 0.01; HR = 2.48; CI = 2.15-2.81) were independently predictive of mortality. A positive AXT ECG (P < 0.05; HR = 2.61; CI = 2.13-3.10) was predictive of MI. Death and MI combined were prognosticated by METs (P < 0.05; HR = 0.63; CI = 0.41-0.85), MPI (P < 0.05; HR = 1.77; CI = 1.49-2.05), and a positive AXT ECG (P < 0.05; HR = 1.86; CI = 1.55-2.17). In conclusion, for high risk older patients who cannot perform leg exercise because of lower extremity disabilities, AXT METs are as important as MPI for prediction of mortality alone and death and MI combined, and a positive AXT ECG prognosticates MI alone and death and MI combined. 相似文献
949.
Wang Z Oh E Clapp DW Chernoff J Thurmond DC 《The Journal of biological chemistry》2011,286(48):41359-41367
The p21-activated kinase PAK1 is implicated in tumorigenesis, and efforts to inhibit PAK1 signaling as a means to induce tumor cell apoptosis are underway. However, PAK1 has also been implicated as a positive effector of mechanisms in clonal pancreatic beta cells and skeletal myotubes that would be crucial to maintaining glucose homeostasis in vivo. Of relevance, human islets of Type 2 diabetic donors contained ~80% less PAK1 protein compared with non-diabetics, implicating PAK1 in islet signaling/scaffolding functions. Mimicking this, islets from PAK1(-/-) knock-out mice exhibited profound defects in the second/sustained-phase of insulin secretion. Reiteration of this specific defect by human islets treated with the PAK1 signaling inhibitor IPA3 revealed PAK1 signaling to be of primary functional importance. Analyses of human and mouse islet beta cell signaling revealed PAK1 activation to be 1) dependent upon Cdc42 abundance, 2) crucial for signaling downstream to activate ERK1/2, but 3) dispensable for cofilin phosphorylation. Importantly, the PAK1(-/-) knock-out mice were found to exhibit whole body glucose intolerance in vivo. Exacerbating this, the PAK1(-/-) knock-out mice also exhibited peripheral insulin resistance. Insulin resistance was coupled to ablation of insulin-stimulated GLUT4 translocation in skeletal muscle from PAK1(-/-) knock-out mice, and in sharp contrast to islet beta cells, skeletal muscle PAK1 loss was underscored by defective cofilin phosphorylation but normal ERK1/2 activation. Taken together, these data provide the first human islet and mammalian in vivo data unveiling the key and crucial roles for differential PAK1 signaling in the multi-tissue regulation of whole body glucose homeostasis. 相似文献
950.
Wade F Espagne A Persuy MA Vidic J Monnerie R Merola F Pajot-Augy E Sanz G 《The Journal of biological chemistry》2011,286(17):15252-15259
G-protein-coupled receptor homo-oligomerization has been increasingly reported. However, little is known regarding the relationship between activation of the receptor and its association/conformational states. The mammalian olfactory receptors (ORs) belong to the G protein-coupled receptor superfamily. In this study, the homo-oligomerization status of the human OR1740 receptor and its involvement in receptor activation upon odorant ligand binding were addressed by co-immunoprecipitation and bioluminescence resonance energy transfer approaches using crude membranes or membranes from different cellular compartments. For the first time, our data clearly show that mammalian ORs constitutively self-associate into homodimers at the plasma membrane level. This study also demonstrates that ligand binding mediates a conformational change and promotes an inactive state of the OR dimers at high ligand concentrations. These findings support and validate our previously proposed model of OR activation/inactivation based on the tripartite odorant-binding protein-odorant-OR partnership. 相似文献